Done deal:€2.7m funding
The clincher: “This award will enable us to accelerate the OncoMasTR test from the laboratory to the clinic, as well as creating employment opportunities.” - Des O’Leary, chief executive, OncoMark
Diagnostic technology that could help breast cancer patients avoid unnecessary post-operative chemotherapy has earned a Dublin start-up €2.7 million in funding.
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team